A 48-week real-world effectiveness of nemolizumab for pediatric patients with atopic dermatitis.
Hagino T, Takahashi Y, Saeki H, Fujimoto E, Kanda N
Journal of the American Academy of DermatologyIn the feed 5 Aug 2026, published online 5 Aug 2026, issue 2026 Aug 05, added to PubMed 5 Aug 2026
Topics: Atopic dermatitis & eczemaItch & prurigoChildrenBiologics
Abstract
PubMed has no abstract for this paper, as is usual for research letters, correspondence and editorials. The publisher’s page has the full paper.
PMID 42556738 · DOI 10.1016/j.jaad.2026.07.118